Oncaspar

Active Ingredient(s): Pegaspargase
FDA Approved: * February 1, 1994
Pharm Company: * ENZON
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Oncaspar Overview

Pegaspargase /pæsprez/, trade name Oncaspar, is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase[1] which has undergone PEGylation. The drug is manufactured by Exelead, Inc. It is used in the treatment of acute lymphoblastic leukemia.[2][3] See also PEGylation References ^ "UNM Cancer Center". Archived from the original on September 3, 2006. Retrieved 2007-08-28..mw-parser-output cite.citation{font-s...

Read more Oncaspar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegaspargase

Recent Oncaspar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pegaspargase
  • Injection: 750IU/ml
  • Vial: 750iu/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Oncaspar: (2 results)

Sorted by National Drug Code
  • 0944-3810 Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution by Baxalta Us Inc.
  • 54482-301 Oncaspar 750 [iu]/Ml Intramuscular; Intravenous Injection, Solution by Sigma-tau Pharmaceuticals, Inc.

Other drugs which contain Pegaspargase or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA